ACCESS Newswire
09 Nov 2025, 01:19 GMT+10
With President Trump signaling openness to marijuana's medical benefits and 39 state attorneys general demanding a crackdown on unregulated hemp-derived THC, MMJ stands as the only federally compliant company prepared to deliver safe, pharmaceutical-grade cannabis treatments. As the nation moves toward a Federal Cannabis Reset, MMJ's FDA and DEA-aligned pathway offers the lawful, science-based solution America needs.
WASHINGTON, DC / ACCESS Newswire / November 8, 2025 / As 39 attorney generals call on Congress to shut down 'intoxicating hemp' loopholes flooding America with unregulated synthetic THC, one company's vision stands validated: MMJ International Holdings.
For seven years, while most of the cannabis industry chased state based shortcuts, MMJ pursued the hard, federally compliant road - the FDA/DEA drug development pathway - a choice now emerging as the cornerstone of the next era of lawful cannabinoid medicine.
'Everyone in Washington is talking about cannabis reform,' said Duane Boise, President & CEO of MMJ International Holdings. 'But at MMJ, we're not watching the speak - we're watching the action. The law, the science, and now 39 Attorneys General all point in the same direction: federal control and pharmaceutical compliance.'
The Federal Reset: DOJ, DEA, and the States Align on One Truth
The Department of Justice's 2025 concession that the DEA's internal court system was unconstitutional marked the beginning of a massive federal realignment. Now, the attorneys general from 37 states and two territories have made it explicit: the 2018 Farm Bill's hemp loophole unleashed an unregulated drug market of 'Frankenstein THC' products, endangering children and undermining public health.
Together, these developments signal a federal cannabis reset - one that eliminates gray-market intoxicants and restores legitimate, FDA-supervised research as the only lawful path.
MMJ has spent years building that lawful infrastructure:
DEA-licensed Schedule I analytical facility (MMJ BioPharma Labs)